(1)
Validity and Reability Test of the Naranjo Questionnaire to Measure Adverse Drug Reactions (ADRs) in Atherosclerosis Patients. B.J 2026, 4 (2), 43-50. https://doi.org/10.30812/biocity.v4i2.5842.